NORM-HF Pivotal Study | MicrobiomeTrials← Back to trialsNCT07574593
NORM-HF Pivotal Study
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-05-29Est. Completion: 2029-08
Enrollment target: 800 participants Locations- Saint Francis Health System, Tulsa, Oklahoma, United States
- North Central Heart - Avera Hospital, Sioux Falls, South Dakota, United States
Other microbiome trials you might be interested in
Mitral Valve ProlapseMitral Regurgitation
Mitral regurgitation (MR) is the second most frequent valvular heart disease and the second most frequent indication for…
Milan, ItalyEst. completion Jun 1, 2029
SARS-CoV-2Influenza, HumanRespiratory Syncytial Virus InfectionsRespiratory Distress SyndromeSystemic Inflammatory Response Syndrome
The purpose of this clinical trial is to evaluate the safety, tolerability and efficacy of two doses (dose A and dose B)…
Alcalá de Henares, SpainEst. completion Oct 2, 2026